Subscribe To
IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced three poster presentations at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023), to be held in San Diego, California on November 1-5, 2023. Two […] The post IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38t...
Read More
Posted: Oct 3 2023, 20:30
Author Name: forextv
Views: 112279